Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 1;97(2):353-358.
doi: 10.1002/ccd.29232. Epub 2020 Aug 31.

Transcatheter mitral valve in ring, hazards of long anterior mitral leaflet and 3-dimensional rings

Nishant Sekaran  1 , Benjamin D Horne  1   2 , John R Doty  1 , Bruce B Reid  1 , Edward C Miner  1 , James R Harkness  1 , Kent W Jones  1 , Camille Michael Minder  1 , William T Caine  1 , Stephen E Clayson  1 , Brian K Whisenant  1
Affiliations

Transcatheter mitral valve in ring, hazards of long anterior mitral leaflet and 3-dimensional rings

Nishant Sekaran et al. Catheter Cardiovasc Interv. .

Abstract

Objectives: The purpose of this study was to define anterior mitral leaflet (AML) length and mitral ring characteristics associated with LVOT obstruction and PVL following MViR.

Background: Transcatheter Mitral Valve in Ring (MViR) procedural complications including parvalvular leak (PVL) and left ventricular outflow tract (LVOT) obstruction are frequent.

Methods: Clinical records, computer tomographic scans (CTs) and echocardiograms of consecutive MViR patients were retrospectively reviewed for anterior mitral leaflet length, CT-simulated neoLVOT, and aortomitral angle among patients with and without MViR-induced LVOT obstruction. Acute and 1-year outcomes are described.

Results: Twenty-two patients underwent MViR. Technical success was achieved in 13/22 (57.1%) patients, limited by paravalvular regurgitation requiring second transcatheter heart valves (THVs) in seven patients. Second valves were needed in 6/11 (54.5%) patients with 3-dimensional rings but 1/11 (9.1%, p = .06) of patients with planar rings. Procedure success at 30 days was achieved in 20/22 (90.9%) patients. There were no procedural, in-hospital, or 30-day deaths. Two patients developed significant LVOT obstruction, one managed with urgent surgery and one with elective alcohol septal ablation. Anterior mitral leaflets were longer among the two patients with LVOT obstruction than the 20 patients who did not develop LVOT obstruction when measured by TEE (30 mm vs. 21 mm, p = .009) or by CT (29 mm vs. 22 mm, p = .026).

Conclusions: AML >25 mm increases the risk of MViR induced LVOT obstruction. PVL is common, particularly in 3-dimensional rings which can be managed with a second THV.

Keywords: mitral valve disease; paravalvular leak; percutaneous intervention; transcatheter valve implantation.

PubMed Disclaimer

Comment in

  • Mitral valve-in-ring: Simply complicated.
    Eng MH, Verma DR. Eng MH, et al. Catheter Cardiovasc Interv. 2021 Feb 1;97(2):359-360. doi: 10.1002/ccd.29494. Catheter Cardiovasc Interv. 2021. PMID: 33587799 No abstract available.

References

REFERENCES

    1. Vassileva CM, Mishkel G, McNeely C, et al. Long-term survival of patients undergoing mitral valve repair and replacement: a longitudinal analysis of Medicare fee-for-service beneficiaries. Circulation. 2013;127(18):1870-1876.
    1. Thourani VH, Weintraub WS, Guyton RA, et al. Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: effect of age and concomitant coronary artery bypass grafting. Circulation. 2003;108(3):298-304.
    1. Kilic A, Acker MA, Gleason TG, et al. Clinical outcomes of mitral valve reoperations in the United States: an analysis of the Society of Thoracic Surgeons National Database. Ann Thorac Surg. 2019;107(3):754-759.
    1. Eleid MF, Whisenant BK, Cabalka AK, et al. Early outcomes of percutaneous transvenous transseptal transcatheter valve implantation in failed bioprosthetic mitral valves, ring annuloplasty, and severe mitral annular calcification. JACC Cardiovasc Interv. 2017;10(19):1932-1942.
    1. Guerrero M, Vemulapalli S, Xiang Q, et al. Thirty-day outcomes of Transcatheter mitral valve replacement for degenerated mitral bioprostheses (valve-in-valve), failed surgical rings (valve-in-ring), and native valve with severe mitral annular calcification (valve-in-mitral annular calcification) in the United States: data from the Society of Thoracic Surgeons/American College of Cardiology/Transcatheter valve therapy registry. Circ Cardiovasc Interv. 2020;13(3):e008425.

MeSH terms

LinkOut - more resources